Evidence map›Paper›PMID 33249421›Full record

ArticleEuropean journal of human genetics : EJHG2021

Reflections on dynamic consent in biomedical research: the story so far.

Harriet J A Teare, Megan Prictor, Jane Kaye

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Expanding the boundaries of previously obtained informed consent in research: Views from participants in the Personalised Risk-based Mammascreening study.Health expectations : an international journal of public participation in health care and health policy · 2023
    Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. 'A No-Brainer, but Not a Simple Decision': A Qualitative Study of Patient Experiences of Tissue Donation for Research in Rare Craniospinal Tumour Pathways.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. The Ethics of Decentralized Clinical Trials and Informed Consent: Taking Technologies' Soft Impacts into Account.Health care analysis : HCA : journal of health philosophy and policy · 2025
    Article
  18. On the ethical governance of swarm robotic systems in the real world.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Harriet J A TeareCentre for Health, Law and Emerging Technologies, Faculty of Law, University of Oxford, Oxford, UK. harriet.teare@law.ox.ac.uk.ORCID http://orcid.org/0000-0002-3783-7547
Megan PrictorHealth, Law and Emerging Technologies, Melbourne Law School, University of Melbourne, Carlton, VIC, Australia.ORCID http://orcid.org/0000-0002-5244-2041
Jane KayeCentre for Health, Law and Emerging Technologies, Faculty of Law, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-7311-4725

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dynamic consent (DC) was originally developed in response to challenges to the informed consent process presented by participants agreeing to 'future research' in biobanking. In the past 12 years, it has been trialled in a number of different projects, and examined as a new approach for consent and to support patient engagement over time. There have been significant societal shifts during this time, namely in our reliance on digital tools and the use of social media, as well as a greater appreciation of the integral role of patients in biomedical research. This paper reflects on the development of DC to understand its importance in an age where digital health is becoming the norm and patients require greater oversight and control of how their data may be used in a range of settings. As well as looking back, it looks forwards to consider how DC could be further utilised to enhance the patient experience and address some of the inequalities caused by the digital divide in society.

Indexed as

Biological Specimen BanksGenetic PrivacyHumansInformed ConsentTissue and Organ ProcurementTissue Donors

Identifiers

PMID33249421
PMCPMC7695991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.